Development
GE HealthCare Technologies Inc.
GEHC
$71.62
$0.070.10%
NASDAQ
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Net Income | -16.63% | -6.73% | 24.88% | -40.00% | -36.32% |
Total Depreciation and Amortization | -3.99% | -0.63% | 34.62% | -24.28% | -23.84% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 0.00% | -323.19% | -1,537.21% | -245.21% | -1,746.15% |
Change in Net Operating Assets | -96.58% | 130.56% | 135.82% | 150.92% | 134.35% |
Cash from Operations | -31.94% | 33.73% | 99.52% | 37.11% | 32.67% |
Capital Expenditure | -22.31% | -17.89% | -56.90% | -2.44% | -3.72% |
Sale of Property, Plant, and Equipment | -75.00% | 0.00% | -66.67% | -91.67% | -73.33% |
Cash Acquisitions | -- | 89.90% | 89.90% | 91.35% | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 122.73% | 80.39% | -54.29% | -29.67% | -24.53% |
Cash from Investing | -39.94% | 74.57% | 67.19% | 73.22% | 82.23% |
Total Debt Issued | -75.81% | 78,330.77% | 145,714.29% | 145,714.29% | 164,080.00% |
Total Debt Repaid | -28,800.00% | -142.86% | -150.00% | -30.77% | 82.35% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 83.14% | -2,175.74% | -2,686.65% | -7,215.64% | -3,552.59% |
Cash from Financing | 52.81% | -14.08% | -124.24% | 191.29% | -265.78% |
Foreign Exchange rate Adjustments | 133.33% | 187.18% | 134.62% | 163.49% | 126.47% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -33.03% | 715.81% | 554.98% | 541.62% | 292.02% |